Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Renata Zelic, Francesca Giunchi, Jonna Fridfeldt, Jessica Carlsson, Sabina Davidsson, Luca Lianas, Cecilia Mascia, Daniela Zugna, Luca Molinaro, Per Henrik Vincent, Gianluigi Zanetti, Ove Andrén, Lorenzo Richiardi, Olof Akre, Michelangelo Fiorentino & Andreas Pettersson. (2022) Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade. Clinical Epidemiology 14, pages 59-70.
Read now
Read now
Kaire Innos, Keiu Paapsi, Indrek Alas, Peep Baum, Martin Kivi, Mihhail Kovtun, Rauno Okas, Helis Pokker, Olga Rajevskaja, Aleksandra Rautio, Mikk Saretok, Elari Valk, Mihhail Žarkovski, Gleb Denissov & Katrin Lang. (2022) Evidence of overestimating prostate cancer mortality in Estonia: a population-based study. Scandinavian Journal of Urology 56:5-6, pages 359-364.
Read now
Read now
Elin Axén, Johan Stranne, Marianne Månsson, Erik Holmberg & Rebecka Arnsrud Godtman. (2022) Biochemical recurrence after radical prostatectomy – a large, comprehensive, population-based study with long follow-up. Scandinavian Journal of Urology 56:4, pages 287-292.
Read now
Read now
J. Stranne, K. Brasso, B. Brennhovd, E. Johansson, F. Jäderling, M. Kouri, W. Lilleby, P. Meidahl Petersen, T. Mirtti, A. Pettersson, A. Rannikko, C. Thellenberg & O. Akre. (2018) SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer. Scandinavian Journal of Urology 52:5-6, pages 313-320.
Read now
Read now
Sven Löffeler, Adrian Halland, Harald Weedon-Fekjær, Anastasia Nikitenko, Christian Lycke Ellingsen & Erik Skaaheim Haug. (2018) High Norwegian prostate cancer mortality: evidence of over-reporting. Scandinavian Journal of Urology 52:2, pages 122-128.
Read now
Read now
Katarina Tomic, Marcus Westerberg, David Robinson, Hans Garmo & Pär Stattin. (2016) Proportion and characteristics of men with unknown risk category in the National Prostate Cancer Register of Sweden. Acta Oncologica 55:12, pages 1461-1466.
Read now
Read now
Katarina Tomic, Anders Berglund, David Robinson, Marie Hjälm-Eriksson, Stefan Carlsson, Mats Lambe & Pär Stattin. (2015) Capture rate and representativity of The National Prostate Cancer Register of Sweden. Acta Oncologica 54:2, pages 158-163.
Read now
Read now
Carl Kilander, Fredrik Mattsson, Rickard Ljung, Jesper Lagergren & Omid Sadr-Azodi. (2014) Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers. Acta Oncologica 53:6, pages 822-829.
Read now
Read now
Ingela Franck Lissbrant, Hans Garmo, Anders Widmark & Pär Stattin. (2013) Population-based study on use of chemotherapy in men with castration resistant prostate cancer. Acta Oncologica 52:8, pages 1593-1601.
Read now
Read now
Articles from other publishers (36)
H.V. Stroomberg, A. Røder, J.T. Helgstrand, K. Brasso & S.B. Larsen. (2023) Evaluation of causes of death among Danish men with initial non-malignant histopathology of the prostate. Ethics, Medicine and Public Health 30, pages 100930.
Crossref
Crossref
Richard Shore, Ji Zhang, Weimin Ye, Pär Stattin & Mats Lindblad. (2023) Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study. Cancer Causes & Control.
Crossref
Crossref
Andri Wilberg Orrason, Johan Styrke, Hans Garmo & Pär Stattin. (2022) Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden. BJU International 131:4, pages 486-493.
Crossref
Crossref
Pär Stattin, Marcus Westerberg, Ingela Franck Lissbrant, Marie Hjälm Eriksson, Anders Kjellman, Anders Ullén, Zdravko Vassilev, Per Sandstrom, Rachel Weinrib, David Martinez & Xabier Garcia-Albeniz. (2023) Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden. Clinical Genitourinary Cancer 21:1, pages 107.e1-107.e9.
Crossref
Crossref
John Maret-Ouda, Giola Santoni, Shaohua Xie, Annika Rosengren & Jesper Lagergren. (2022) Objectively confirmed gastroesophageal reflux disease and risk of atrial fibrillation: a population-based cohort study in Sweden. European Journal of Gastroenterology & Hepatology 34:11, pages 1116-1120.
Crossref
Crossref
Magdalena Lycken, Oskar Bergengren, Linda Drevin, Hans Garmo, Marcus Westerberg, Elin Axén, Johan Stranne, Lars Holmberg & Anna Bill-Axelson. (2022) Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths. European Urology Open Science 41, pages 81-87.
Crossref
Crossref
Lars Björnebo, Tobias Nordström, Andrea Discacciati, Thorgerdur Palsdottir, Markus Aly, Henrik Grönberg, Martin Eklund & Anna Lantz. (2022) Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality. JAMA Oncology 8:7, pages 1019.
Crossref
Crossref
Jatinderpal K. Kalsi, Andy Ryan, Aleksandra Gentry-Maharaj, Danielle Margolin-Crump, Naveena Singh, Matthew Burnell, Elizabeth Benjamin, Sophia Apostolidou, Mariam Habib, Susan Massingham, Chloe Karpinskyj, Robert Woolas, Martin Widschwendter, Lesley Fallowfield, Stuart Campbell, Steven Skates, Alistair McGuire, Max Parmar, Ian Jacobs & Usha Menon. (2021) Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar. Trials 22:1.
Crossref
Crossref
Rebecka Arnsrud Godtman, Sebastiaan Remmers, Gunnar Aus, Vera Nelen, Liesbet van Eycken, Arnauld Villers, Xavier Rebillard, Maciej Kwiatkowski, Stephen Wyler, Donella Puliti, Giuseppe Gorini, Alvaro Paez, Marcos Lujan, Teuvo Tammela, Chris Bangma, Anssi Auvinen & Monique J. Roobol. (2021) Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer. European Urology Open Science 34, pages 27-32.
Crossref
Crossref
Elsa Brånvall, Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M. Birmann & Karin E. Smedby. (2021) Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era. British Journal of Haematology 195:4, pages 552-560.
Crossref
Crossref
Khaldoon Aljerian, Rimah A. Almohammed, Taghred M. Alghaith, Quds Al-Saffer, Nahar M. Alazmi & Ahmed S. BaHammam. (2021) Unifying the death notification form: Recommendations by the Saudi Health Council task force. Journal of Taibah University Medical Sciences 16:5, pages 672-682.
Crossref
Crossref
Frederik B. Thomsen, Hans Garmo, Klaus Brasso, Lars Egevad & Pär Stattin. (2021) Temporal changes in cause‐specific death in men with localised prostate cancer treated with radical prostatectomy: a population‐based, nationwide study. Journal of Surgical Oncology 124:5, pages 867-875.
Crossref
Crossref
Richard Shore, Jingru Yu, Weimin Ye, Jesper Lagergren, Martin Rutegård, Olof Akre, Pär Stattin & Mats Lindblad. (2021) Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer. Scientific Reports 11:1.
Crossref
Crossref
Marcus Westerberg, Rolf Larsson, Lars Holmberg, Pär Stattin & Hans Garmo. (2020) Simulation model of disease incidence driven by diagnostic activity. Statistics in Medicine 40:5, pages 1172-1188.
Crossref
Crossref
Elsa Brånvall, Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M. Birmann & Karin E. Smedby. (2020) Statin use is associated with improved survival in multiple myeloma: A Swedish population‐based study of 4315 patients. American Journal of Hematology 95:6, pages 652-661.
Crossref
Crossref
Emmeli Palmstedt, Marianne Månsson, Maria Frånlund, Johan Stranne, Carl-Gustaf Pihl, Jonas Hugosson & Rebecka Arnsrud Godtman. (2019) Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort. European Urology Oncology 2:6, pages 716-722.
Crossref
Crossref
Renata Zelic, Daniela Zugna, Matteo Bottai, Ove Andrén, Jonna Fridfeldt, Jessica Carlsson, Sabina Davidsson, Valentina Fiano, Michelangelo Fiorentino, Francesca Giunchi, Chiara Grasso, Luca Lianas, Cecilia Mascia, Luca Molinaro, Gianluigi Zanetti, Lorenzo Richiardi, Andreas Pettersson & Olof Akre. (2019) Estimation of Relative and Absolute Risks in a Competing-Risks Setting Using a Nested Case-Control Study Design: Example From the ProMort Study. American Journal of Epidemiology 188:6, pages 1165-1173.
Crossref
Crossref
Mary Nguyen-Nielsen, Henrik Møller, Anne Tjønneland & Michael Borre. (2019) Causes of death in men with prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata). Cancer Epidemiology 59, pages 249-257.
Crossref
Crossref
Magdalena Lycken, Linda Drevin, Hans Garmo, Pär Stattin, Jan Adolfsson, Ingela Franck Lissbrant, Lars Holmberg & Anna Bill-Axelson. (2018) The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European data. European Journal of Cancer 88, pages 101-108.
Crossref
Crossref
Frederik Birkebæk Thomsen, Fredrik Sandin, Hans Garmo, Ingela Franck Lissbrant, Göran Ahlgren, Mieke Van Hemelrijck, Jan Adolfsson, David Robinson & Pär Stattin. (2017) Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study. European Urology 72:6, pages 920-928.
Crossref
Crossref
Pär Stattin, Fredrik Sandin, Frederik Birkebæk Thomsen, Hans Garmo, David Robinson, Ingela Franck Lissbrant, Håkan Jonsson & Ola Bratt. (2017) Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. European Urology 72:1, pages 125-134.
Crossref
Crossref
Stephen D Walter, Harry J de Koning, Jonas Hugosson, Kirsi Talala, Monique J Roobol, Sigrid Carlsson, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Álvaro Páez, Sue Moss & Anssi Auvinen. (2016) Impact of cause of death adjudication on the results of the European prostate cancer screening trial. British Journal of Cancer 116:1, pages 141-148.
Crossref
Crossref
Sigrid Carlsson, Melissa Assel, David Ulmert, Axel Gerdtsson, Jonas Hugosson, Andrew Vickers & Hans Lilja. (2017) Screening for Prostate Cancer Starting at Age 50–54 Years. A Population-based Cohort Study. European Urology 71:1, pages 46-52.
Crossref
Crossref
Kathryn M. Wilson, Sarah C. Markt, Fang Fang, Caroline Nordenvall, Jennifer R. Rider, Weimin Ye, Hans-Olov Adami, Pär Stattin, Olof Nyrén & Lorelei A. Mucci. (2016) Snus use, smoking and survival among prostate cancer patients. International Journal of Cancer 139:12, pages 2753-2759.
Crossref
Crossref
Tuomas P. Kilpeläinen, Tuukka Mäkinen, Pekka J. Karhunen, Jussi Aro, Jorma Lahtela, Kimmo Taari, Kirsi Talala, Teuvo L.J. Tammela & Anssi Auvinen. (2016) Estimating bias in causes of death ascertainment in the Finnish Randomized Study of Screening for Prostate Cancer. Cancer Epidemiology 45, pages 1-5.
Crossref
Crossref
Emma L Turner, Chris Metcalfe, Jenny L Donovan, Sian Noble, Jonathan A C Sterne, J Athene Lane, Eleanor I Walsh, Elizabeth M Hill, Liz Down, Yoav Ben-Shlomo, Steven E Oliver, Simon Evans, Peter Brindle, Naomi J Williams, Laura J Hughes, Charlotte F Davies, Siaw Yein Ng, David E Neal, Freddie C Hamdy, Peter Albertsen, Colette M Reid, Jon Oxley, John McFarlane, Mary C Robinson, Jan Adolfsson, Anthony Zietman, Michael Baum, Anthony Koupparis & Richard M Martin. (2016) Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee. British Journal of Cancer 115:1, pages 90-94.
Crossref
Crossref
Mieke Van Hemelrijck, Yasin Folkvaljon, Jan Adolfsson, Olof Akre, Lars Holmberg, Hans Garmo & Pär Stattin. (2016) Causes of death in men with localized prostate cancer: a nationwide, population-based study. BJU International 117:3, pages 507-514.
Crossref
Crossref
Rebecka Arnsrud Godtman, Erik Holmberg, Hans Lilja, Johan Stranne & Jonas Hugosson. (2015) Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial. European Urology 68:3, pages 354-360.
Crossref
Crossref
Sandip M. Prasad & Jim C. Hu. (2015) Reply to P. Stattin. Journal of Clinical Oncology 33:9, pages 1087-1087.
Crossref
Crossref
Katarina Tomic, Fredrik Sandin, Annette Wigertz, David Robinson, Mats Lambe & Pär Stattin. (2015) Evaluation of data quality in the National Prostate Cancer Register of Sweden. European Journal of Cancer 51:1, pages 101-111.
Crossref
Crossref
P. Stattin, S. Carlsson, B. Holmstrom, A. Vickers, J. Hugosson, H. Lilja & H. Jonsson. (2014) Prostate Cancer Mortality in Areas With High and Low Prostate Cancer Incidence. JNCI Journal of the National Cancer Institute 106:3, pages dju007-dju007.
Crossref
Crossref
M. Van Hemelrijck, A. Wigertz, F. Sandin, H. Garmo, K. Hellstrom, P. Fransson, A. Widmark, M. Lambe, J. Adolfsson, E. Varenhorst, J.-E. Johansson, P. Stattin, L. Drevin, A. Bill-Axelson, D. Robinson & O. Akre. (2012) Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0. International Journal of Epidemiology 42:4, pages 956-967.
Crossref
Crossref
Simon Chowdhury, David Robinson, Declan Cahill, Alejo Rodriguez‐Vida, Lars Holmberg & Henrik Møller. (2013) Causes of death in men with prostate cancer: an analysis of 50 000 men from the Thames Cancer Registry. BJU International 112:2, pages 182-189.
Crossref
Crossref
Jennifer R. Rider, Fredrik Sandin, Ove Andrén, Peter Wiklund, Jonas Hugosson & Pär Stattin. (2013) Long-term Outcomes Among Noncuratively Treated Men According to Prostate Cancer Risk Category in a Nationwide, Population-based Study. European Urology 63:1, pages 88-96.
Crossref
Crossref
Ruth Etzioni, Lorelei Mucci, Shu Chen, Jan-Erik Johansson, Katja Fall & Hans-Olov Adami. (2012) Increasing Use of Radical Prostatectomy for Nonlethal Prostate Cancer in Sweden. Clinical Cancer Research 18:24, pages 6742-6747.
Crossref
Crossref
Michael Rink, Harun Fajkovic, Eugene K. Cha, Amit Gupta, Pierre I. Karakiewicz, Felix K. Chun, Yair Lotan & Shahrokh F. Shariat. (2012) Death Certificates Are Valid for the Determination of Cause of Death in Patients With Upper and Lower Tract Urothelial Carcinoma. European Urology 61:4, pages 854-855.
Crossref
Crossref